Convoluted Regulatory Requirements
Early phase clinical trials are subject to complex regulation and red tape. The approval process is lengthy, confusing, and never guaranteed.
Competition From Established Players
Established life sciences companies have greater brand recognition and existing relationships, making it harder for startups to gain traction and success.
Disinterested Clinical Research Sites
Medtech and Biopharma startups often struggle to secure access to healthcare providers. Many hospitals aren’t willing to participate in clinical trials using new medical products.
Prolonged Subject Recruitment
Quickly recruiting patients for early-phase clinical trials is close to impossible. Potential patients are often reluctant, have too many options, or are ineligible.
Limited Financial Resources
Medtech and Biopharma startups often lack the financial resources and infrastructure to manage their trials, recruit patients, and collect data to analyze.
bioaccess® is your gateway to the untapped potential of conducting cost-effective, fast, and high-quality early-phase clinical research studies across Latin America.
We excel in assisting startups with executing medical device and biopharmaceutical clinical trials. With a robust presence throughout Latin America, Eastern Europe, and Australia, we are devoted to offering exceptional support and guidance for your project.
Our expertise and far-reaching network enable us to effectively manage trials in multiple countries, ensuring dependable and timely outcomes.
Collaborate with us and experience the certainty of working with a Medtech CRO committed to your success.
bioaccess® will quickly and reliably deliver regulatory approval, clinical research site activation, patient recruitment, and trial data.
We connect innovative Medtech and Biopharma startups with top-ranked clinical research sites in Latin America, Eastern Europe, and Australia, bringing certainty in:
✔️ Moving to the next phase (an FDA IDE/IND pivotal/phase III study)
✔️ Raising funds
✔️ A successful exit